Gynecologic cancers collectively account for 15.2 % of cancer cases annually and remain the leading cause of cancer-related death among female patients worldwide [1]. They are associated with a substantial health care burden with over 8.9 million disability-adjusted life years globally [2]. A substantial proportion of patients undergoing treatment for gynecologic cancer experience complications, with 83.8 % facing persistent or long-term effects beyond the treatment period, highlighting the need…